Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple Sclerosis
Unknown statusPhase 3NCT02059096
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is designed to evaluate the effect of repetitive Transcranial Magnetic Stimulation (rTMS) in the resolution of chronic pain. Participants will be patients with Multiple Sclerosis suffering from chronic pain of neurological origin.
Study details
- Official title
- Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple Sclerosis
- Conditions
- Multiple Sclerosis With Central Neuropathic Pain
- Sponsor
- University Hospital, Clermont-Ferrand
- Start date
- 2014-01-05
- Primary completion
- 2023-02
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * relapsing-remitting Multiple Sclerosis * 18 to 60 years * central neuropathic pain with a DN4 score of 4 or more out of 10 * average pain of at least 4/10 * presence of pain at least 4 days per week * presence of pain for at least 3 months * stable analgesic treatment Exclusion Criteria: * relapse during the previous 30 days * contraindication for rTMS * peripheral neuropathic pain * severe depression * epilepsia * resting motor threshold above 75%
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02059096